Form 4: SOPHiA GENETICS Officer Sells Shares for Tax Obligations

SOPHiA GENETICS SA reports that Chief Sales Officer Kevin Puylaert sold 33 ordinary shares to cover tax obligations related to vested restricted stock units.

Summary

• Kevin Puylaert, Chief Sales Officer at SOPHiA GENETICS SA, sold 33 ordinary shares on May 19, 2026.
• The sale was conducted to satisfy tax obligations arising from the vesting of restricted stock units on May 18, 2026.
• These transactions were executed as 'sell to cover' and are not discretionary trades.
• Following the transaction, Puylaert beneficially owns 148,164 ordinary shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the share sale is for tax purposes and not indicative of a change in management's confidence.

Positives

• The sale was a 'sell to cover' transaction to meet tax obligations, indicating it was not a discretionary decision to divest from the company.
• The reporting person continues to beneficially own a significant number of shares (148,164) directly.

Negatives

• A sale of shares, even for tax purposes, represents a reduction in the reporting person's direct holdings.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to a change in beneficial ownership.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. This particular filing indicates a routine sale to cover tax liabilities, which is common when restricted stock units vest. It does not suggest a change in the insider's conviction about the company's prospects.

Stakeholder Impact

• Shareholders: The sale of 33 shares by an insider is unlikely to have a significant impact on the share price due to the small volume.

Key Dates

Keywords

SOPHiA GENETICS SA, Form 4, Insider Trading, Share Sale, Tax Obligations, Restricted Stock Units, Chief Sales Officer, Beneficial Ownership